Thomas Soeiro

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Intimate Partner Violence

Major Depressive Disorder

Postoperative Pain

Top Venues

Fundamental & clinical pharmacology

Addiction (Abingdon, England)

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs (2024)
Pauline Gandolfo, Thomas Soeiro, Élisabeth Jouve, Bruno Revol, Amélie Daveluy, Célian Bertin, Céline Eiden, Valérie Gibaja, Leila Chaouachi, Marie-Christine Pérault-Pochat, Cécile Chevallier, Aurélie Aquizérate, Reynald Le Boisselier, Louise Carton, Maryse Lapeyre Mestre, Elisabeth Frauger, Clémence Lacroix, Joëlle Micallef
Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network. Fundamental & clinical pharmacology (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Correction to: Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs (2024)
Thomas Soeiro, Vincent Pradel, Maryse Lapeyre Mestre, Joëlle Micallef
Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: A nationwide, repeated cross-sectional study. Addiction (Abingdon, England) (2023)
Anne Roussin, Thomas Soeiro, Charlotte Fouque, Emilie Jouanjus, Elisabeth Frauger, Nathalie Fouilhé, Michel Mallaret, Joëlle Micallef, Maryse Lapeyre Mestre, null null
Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data. British journal of clinical pharmacology 88 (8) (2022)
Thomas Soeiro, Joëlle Micallef
Commentary on Perry et al.: New means, new measures-without discarding all the previous ones! Addiction (Abingdon, England) 117 (1) (2021)
Jules Baudot, Thomas Soeiro, Marine Tambon, Nicolas Navarro, Gwenaëlle Veyrac, Salim Mezaache, Joëlle Micallef
Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti-depressive drug on the market. Fundamental & clinical pharmacology 36 (3) (2021)
Robinson Gravier Dumonceau, Thomas Soeiro, Clémence Lacroix, Adeline Giocanti, Élisabeth Frauger, Salim Mezaache, Joëlle Micallef
Antidepressants abuse in subjects with opioid use disorders: A 10-year study in the French OPPIDUM program. Fundamental & clinical pharmacology (2021)
Thomas Soeiro, Elisabeth Frauger, Vincent Pradel, Joëlle Micallef
Doctor shopping for methylphenidate as a proxy for misuse and potential abuse in the 67 million inhabitants in France. Fundamental & clinical pharmacology 35 (4) (2020)